Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 19;14(20):3029.
doi: 10.3390/ani14203029.

Clinical Pathology Evaluation in Pet Rabbits Vaccinated Against Rabbit Hemorrhagic Disease Virus 2 (RHDV2)

Affiliations

Clinical Pathology Evaluation in Pet Rabbits Vaccinated Against Rabbit Hemorrhagic Disease Virus 2 (RHDV2)

Chris Griffin et al. Animals (Basel). .

Abstract

A recombinant vaccine for rabbit hemorrhagic disease virus 2, a highly pathogenic virus, was granted emergency use authorization in the United States after the detection and spread of the virus starting in 2018. The goal of the current study was to assess pet rabbits (n = 29) through physical examination and routine clinical pathology testing using repeated assessments post-vaccination. In addition, seroconversion was also monitored after the initial vaccination and booster vaccination. Neither owners nor clinicians detected any physical abnormalities in relationship to the vaccine protocol. Hematological and clinical biochemistry testing showed some changes although median values were within species specific reference intervals. A significant increase in antibody levels was observed at day 21 (post-initial vaccination) and day 49 (post-booster vaccination) versus that present at baseline (p < 0.0001). However, variability in study rabbits was noted with some individuals showing low antibody levels as well as a lower overall response in older rabbits (r = -0.56, p = 0.006). A second cohort of rabbits was assessed at 11-12 months post-initial vaccination. In this second group, antibody levels were not significantly different from baseline levels (p = 0.21). Additional studies should be conducted to further define the variability in seroconversion and the term of protection in pet rabbits as the industry moves forward in the optimization of RHDV2 vaccines.

Keywords: ELISA; RHDV2; antibody; biochemistry; hematology; lagomorph.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Antibody levels to RHDV at baseline (day 0–1, n = 22), day 21 (n = 22), and day 49 (n = 22) in the original cohort of samples. Additional samples were collected from a second cohort of rabbits on day 330–365 (n = 11). Statistical difference of p < 0.0001 versus day 0–1 indicated by **.
Figure 2
Figure 2
Antibody levels over time as observed in three subgroups of rabbits. Mean and standard deviation (error bars) are represented. Data are inclusive of n = 22 rabbits with complete protocol timepoints.

Similar articles

References

    1. Liu S., Xue H., Pu B., Qian N. A new viral disease in rabbits. Anim. Husb. Vet. Med. (Xumu Yu Shouyi) 1984;16:253–255.
    1. Abrantes J., van der Loo W., Le Pendu J., Esteves P.J. Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): A review. Vet. Res. 2012;43:12. doi: 10.1186/1297-9716-43-12. - DOI - PMC - PubMed
    1. Root J.J., Gidlewski T. Rabbit Hemorrhagic Disease. In: Jessup D.A., Radcliffe R.W., editors. Wildlife Disease and Health in Conservation. John Hopkins University Press; Baltimore, MD, USA: 2023. pp. 259–272.
    1. Müller C., Hrynkiewicz R., Bębnowska D., Maldonado J., Baratelli M., Köllner B., Niedźwiedzka-Rystwej P. Immunity against Lagovirus europaeus and the Impact of the Immunological Studies on Vaccination. Vaccines. 2021;9:255. doi: 10.3390/vaccines9030255. - DOI - PMC - PubMed
    1. McMahon S.A., Wigham E. ‘All Ears’: A questionnaire of 1516 owner perceptions of the mental abilities of pet rabbits, subsequent resource provision, and the effect on welfare. Animals. 2020;10:1730. doi: 10.3390/ani10101730. - DOI - PMC - PubMed

LinkOut - more resources